Fitzpatrick Skin Types: IPL Safety for MGD and Rosacea
Why skin type drives IPL risk
The Fitzpatrick classification describes skin Types I to VI based on baseline pigmentation and response to ultraviolet (UV) exposure. In intense pulsed light (IPL) for meibomian gland dysfunction (MGD) and ocular rosacea, Fitzpatrick type is one of the most important factors in determining how aggressively you can treat while protecting the epidermis.
Melanin is a competing chromophore. Lighter skin types (I and II) have less epidermal melanin, which typically allows higher fluence and shorter pulse durations with a wider safety margin. Darker skin types (V and VI) have denser epidermal melanin that absorbs more of the delivered energy, increasing the risk of burns, dyspigmentation, and scarring if standard settings are used.
Selective photothermolysis in MGD treatment
IPL relies on selective photothermolysis. Pulsed broad-spectrum light is absorbed by target chromophores, primarily hemoglobin in telangiectatic vessels and melanin in the epidermis and hair follicles. In MGD and ocular rosacea, the goal is to reduce the inflammatory contribution of abnormal periocular vessels. As skin type increases, more energy is absorbed by epidermal melanin, the therapeutic window narrows, and the margin between effective and injurious fluence becomes smaller.
Practical safety protocols and test spots
For Types III and IV, or for any patient with recent sun exposure, a test spot in a discreet preauricular area can help assess tolerance before completing a full treatment pass. After the test spot, assess for excessive erythema, edema, or early blistering before proceeding.
Use an appropriate coupling gel and confirm that the selected filter (for example, 590 nm versus 615 nm) and fluence range follow the manufacturer's recommendations for that Fitzpatrick type. When in doubt, start more conservatively with lower fluence, longer pulse durations, and staged escalation across sessions rather than aiming for maximal effect in a single visit.